Oramed Pharmaceuticals Inc. Common Stock (ORMP)
Stock · NASDAQ · Health Care
$5.03as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About ORMP
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharm…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- oramed.com
Fundamentals
- 1-day range
- $4.71$4.94
- Market cap
- $178.87M
- P/E (trailing)
- 1.16
- P/E (forward)
- -59.88
- EPS (trailing)
- $4.13
- Dividend yield
- 5.22%
- Beta
- 1.16
- Avg. volume
- 293.8K
- Ex-dividend date
- January 16, 2026
- Dividend pay date
- January 26, 2026
How Oramed Pharmaceuticals Inc. Common Stock Makes Money
Where the revenue actually goes — FY2022 annual results
Source: 10-K filed Mar 6, 2023 · via SEC EDGAR / Finnhub
Oramed Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ORMPOramed Pharmaceuticals Inc. Common Stock$5.03▼ 1.37%Market cap $178.87MP/E 1.16$2.06$5.19
- CRBPCorbus Pharmaceuticals Holdings Inc. Common Stock$10.92▼ 1.93%Market cap $180.46MP/E —$7.12$20.56
- LFCRLifecore Biomedical Inc. Common Stock$4.58▲ 0.88%Market cap $181.55MP/E —$3.63$8.98
- KRROKorro Bio Inc. Common Stock$12.94▼ 2.41%Market cap $174.80MP/E —$5.2$55.89
- ARCTArcturus Therapeutics Holdings Inc. Common Stock$15.19▼ 6.06%Market cap $172.81MP/E —$5.5$24.17
- TNXPTonix Pharmaceuticals Holding Corp. Common Stock$13.59▲ 0.18%Market cap $185.71MP/E —$9.4$33.22
- OKUROnKure Therapeutics Inc. Class A Common Stock$3.78▼ 1.31%Market cap $168.06MP/E —$2.23$5.38
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ORMP Oramed Pharmaceuticals Inc. Common Stock | $178.87M | 1.16 | $5.03 | ▼ 1.37% | $2.06$5.19 |
| CRBP Corbus Pharmaceuticals Holdings Inc. Common Stock | $180.46M | — | $10.92 | ▼ 1.93% | $7.12$20.56 |
| LFCR Lifecore Biomedical Inc. Common Stock | $181.55M | — | $4.58 | ▲ 0.88% | $3.63$8.98 |
| KRRO Korro Bio Inc. Common Stock | $174.80M | — | $12.94 | ▼ 2.41% | $5.2$55.89 |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | $172.81M | — | $15.19 | ▼ 6.06% | $5.5$24.17 |
| TNXP Tonix Pharmaceuticals Holding Corp. Common Stock | $185.71M | — | $13.59 | ▲ 0.18% | $9.4$33.22 |
| OKUR OnKure Therapeutics Inc. Class A Common Stock | $168.06M | — | $3.78 | ▼ 1.31% | $2.23$5.38 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Joshua Hexter · July 2, 2026 · Option Exercise50.0K @ $3.69
- Joshua Hexter · July 1, 2026 · Sale137.0K @ $4.46
- Avraham Gabay · July 1, 2026 · Sale73.4K @ $4.51
- Nadav Kidron · March 30, 2026 · Tax Withholding44.8K @ $3.31
- Miriam Kidron · March 30, 2026 · Tax Withholding435.1K @ $3.31
- Miriam Kidron · March 17, 2026 · Grant119.6K
- Nadav Kidron · March 17, 2026 · Grant167.0K
- Joshua Hexter · March 17, 2026 · Grant95.9K
- Avraham Gabay · March 17, 2026 · Grant95.9K
- Nadav Kidron · March 12, 2026 · Gift100.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 13.23M
- Total value held
- $44.75M
- Institutional holders
- 63
- Unknown3.17M
- Unknown2.11M
- Unknown1.91M
- Unknown1.64M
- Unknown1.32M
- Unknown600.7K
- Unknown259.6K
- Unknown233.0K
- Unknown158.2K
- Unknown157.6K
See the full, filterable feed with live charts on the MarketWall dashboard.